NEW YORK--(BUSINESS WIRE)--AccurKardia, an ECG-led diagnostics software company, today announced a multi-year agreement with Lucem Health, a leading provider of clinical AI solutions. The partnership ...

With cases of arrhythmia and heart disease on the rise—thanks in large part to an aging global population—more tools and technologies are needed to speed up the process of diagnosing and beginning ...

The FDA has granted 510(k) clearance to Biofourmis’ RhythmAnalytics, a cloud-based software product that uses deep learning to read and interpret cardiac arrhythmias. According to a statement from the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Automated ECG interpretation system gains FDA clearance ...

This investment will support AccurKardia’s mission to deliver world class clinical-grade ECG interpretation software to cardiac monitoring companies, thereby expanding access to the benefits of remote ...

The new Holter Program is designed to meet the intricate needs of modern cardiology practices, making cardiac care more seamless, accessible, and scalable. UltraLinQ Launches New Wearable Holter ...

REDWOOD CITY, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has filed a 510(k) ...

Vuno Inc. has received its third breakthrough device designation from South Korea’s Ministry of Food and Drug Safety (MFDS), for its artificial intelligence (AI)-based electrocardiogram (ECG) analysis ...

REDWOOD CITY, Calif., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it is finalizing its FDA ...